
An age-stratified analysis of Swedish national registry data found that myocardial infarction and heart failure rates may even be more prevalent in patients with T1D.

An age-stratified analysis of Swedish national registry data found that myocardial infarction and heart failure rates may even be more prevalent in patients with T1D.

A study of more than 74,000 in China from 2006 to 2015 found that cardiovascular health scores are associated with subsequent risk of CVD events.

Why are major adverse cardiovascular events not treated as the concern risk factors they are in patients with obstructive sleep apnea?

How wearable devices and their massive patient pools have created a balancing act between mass patient arrhythmia data collection and individualized care.

How does a cardiologist balance the benefits of invasive care with the patients' interest in non-invasive measures?

A healthy plant-based diet can reduce a person's risk of developing CKD by 14% and can also help slow the decline of kidney function, according to a new study.

New COMMANDER HF post hoc data shows more evidence the blood-thinning therapy has some effect on potentially deadly cardiovascular events.

The Apple Watch-friendly platform is the first cleared by the FDA to detect and report the 3 common arrhythmias, including atrial fibrillation.

Investigators found that a plant-based diet was associated with a 41% reduction in heart failure risk, while a “southern” diet heavy in fried food, added fats, and eggs was associated with a 72% increase in risk.

Investigators found that participants who never ate breakfast were 87% more likely to die from cardiovascular disease and stroke than those who ate breakfast every day.

Study finds that, despite the creation of the Hospital Readmissions Reduction Program, US and Canada saw similar declines in HF readmission rates.

Ivabradine can be an important tool to lower heart rates in patients with heart failure, but a new study finds usage rates are low when physicians aren’t proactive about initiating the therapy.

Investigators found readmission risk was 4 times greater in patients with stays of 2 days or less.

A study of patients recommended for statin therapy under ACC/AHA guidelines, but not taking any, found that 59.2% reported never being offered a statin.

A new cohort assessment shows white and African American men both have a lifetime hypertension risk of more than 80%.

Investigators observed a 22% and 20% increased risk of heart failure during the 2 most severe influenza seasons.

How the PIONEER-HF and PARADIGM-HF trials have focused on varied, but realistic heart failure patients.

A year-long outpatient care study showed that patients with type 2 diabetes and comorbid cardiovascular disease are 5 times as likely to visit a cardiologist.

A new long-term data analysis reports that about 50% of patients adhere to the critcal therapy after just 1 year, and the rate continues to drop after that.

The breakthrough device is indicated to improve 6-minute walk distance for certain patients with chronic heart failure.

With cardiovascular drug classes inhibitors owning discussion, how will recent or upcoming guideline updates address their use alongside lifestyle management?

Progress in invasive measures for cardiovascular conditions has allowed clinicians the ability to venture into new ground.

An extension of the study showed sacubitril/valsartan's benefit as an initial hospitalized heart failure therapy.

How alirocumab fared for patients with polyvascular disease in a subset of the major clinical trial.

Heart disease is the greatest cause of death in women, and Wood believes female patients would better from a multidisciplinary approach.